SLC16A3 and prostate cancer: MCT4 inhibition appears to inhibit castration-resistant prostate cancer PC-3 cell line invasion and migration, leading to a low transcription and expression levels of invasion-related genes in castration-resistant prostate cancer (Figure 3(Fig. 3)).